Drug Shortage Report for TEVA-COMBO STERINEBS
Report ID | 176827 |
Drug Identification Number | 02272695 |
Brand name | TEVA-COMBO STERINEBS |
Common or Proper name | TEVA-IPRATROP SALB 0.5/2.5MG |
Company Name | TEVA CANADA LIMITED |
Market Status | MARKETED |
Active Ingredient(s) | IPRATROPIUM BROMIDE SALBUTAMOL |
Strength(s) | 0.5MG 2.5MG |
Dosage form(s) | SOLUTION |
Route of administration | INHALATION INHALATION |
Packaging size | 20 |
ATC code | R03AL |
ATC description | ADRENERGICS, INHALANTS |
Reason for shortage | Disruption of the manufacture of the drug. |
Anticipated start date | |
Actual start date | 2022-12-01 |
Estimated end date | 2022-12-20 |
Actual end date | 2022-12-07 |
Shortage status | Resolved |
Updated date | 2022-12-08 |
Company comments | |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 30 NOVOPHARM COURT TORONTO, ONTARIO CANADA M1B 2K9 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v5 | 2022-12-08 | French | Compare |
v4 | 2022-12-08 | English | Compare |
v3 | 2022-12-02 | English | Compare |
v2 | 2022-12-01 | French | Compare |
v1 | 2022-12-01 | English | Compare |
Showing 1 to 5 of 5